{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Warnings by drug regulators about the safety of Paxil, one of the world's most prescribed antidepressants, are reopening seemingly settled questions about a whole class of drugs that also includes Prozac and Zoloft. Doctors are just beginning to react to the finding -- reported first by British drug authorities in June and then endorsed the next week by the Food and Drug Administration -- that unpublished studies about Paxil show that it carries a substantial risk of prompting teenagers and children to consider suicide.", "headline": {"main": "Debate Resumes on the Safety Of Depression's Wonder Drugs"}, "abstract": null, "print_page": "1", "word_count": 2375, "_id": "4fd243ca8eb7c8105d7ddc62", "snippet": "Warnings by drug regulators about the safety of Paxil, one of the world's most prescribed antidepressants, are reopening seemingly settled questions about a whole class of drugs that also includes Prozac and Zoloft.    Doctors are just beginning to...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/07/business/debate-resumes-on-the-safety-of-depression-s-wonder-drugs.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2003-08-07T00:00:00Z", "section_name": "Front Page; Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Bush administration will soon propose significant cuts in Medicare payments for cancer drugs, based on new data suggesting that the government pays far more than the market price for such medicines, administration officials said today. The officials said they would also propose a modest increase in payments to doctors who give the drugs to patients in their offices. But, government documents show, the increased payments for medical services would be dwarfed by the cuts in payments to doctors for the drugs they buy.", "headline": {"main": "Cancer Drugs Face Funds Cut In a Bush Plan"}, "abstract": "Bush administration to propose significant cuts in Medicare payments for cancer drugs, based on new data suggesting government pays far more than market price for such medicines; also plans modest increase in payments to doctors who give drugs to patients in offices; administrator Thomas A Scully explains; Congress is considering similar cuts as part of Medicare drug coverage legislation; administration estimates that oncologists made $700 million in 'Medicare drug profits' last year because such payments were in excess of widely available prices; says doctors typically pay 66-87 percent of average wholesale price; examples cited (M)", "print_page": "1", "word_count": 974, "_id": "4fd22c598eb7c8105d7b8662", "snippet": "The Bush administration will soon propose significant cuts in Medicare payments for cancer drugs, based on new data suggesting that the government pays far more than the market price for such medicines, administration officials said today.    The...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/06/us/cancer-drugs-face-funds-cut-in-a-bush-plan.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "persons", "value": "SCULLY, THOMAS A"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2003-08-06T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Education Life Supplement", "lead_paragraph": "IGNORE the razor wire twisted outside the windows, and the school building at the Sing Sing Correctional Facility feels like most other academic institutions. Classrooms are filled with blackboards, freestanding globes, desk-and-chair combinations. Inspirational messages line the walls: If you don't get it, try again! Some people have to learn the hard way! Never settle for less than your best! But here, 30 miles up the Hudson from New York City, students don't linger after class. They are herded back to their cells the minute the clock hits 8:30. On this night, Rosemarie Murray's ''Written English and Literary Studies I'' class is discussing the plays read over the semester: ''Oedipus,'' ''Hamlet,'' ''Othello'' and ''A Doll's House.'' Last week they had been asked to answer essay questions, and Dr. Murray hands back their responses.", "headline": {"main": "Cons In Class"}, "abstract": "Sentiment against higher education in prison grows as states squeeze budgets of public universities and many question value of humanities education for inmates who may never be released; five New York State prisons have degree-granting programs and some prisoners see those programs as break from tedium of prison life or as ticket to eventual life outside prison walls; profiles of Rosemarie Murray, who teaches literature to inmates, and two prisoner-students Juan Roldan and Sean Pico; photos (special section, Education Life) (L)", "print_page": "28", "word_count": 2784, "_id": "4fd22c558eb7c8105d7b82ff", "snippet": "IGNORE the razor wire twisted outside the windows, and the school building at the Sing Sing Correctional Facility feels like most other academic institutions. Classrooms are filled with blackboards, freestanding globes, desk-and-chair combinations....", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/03/education/cons-in-class.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PICO, SEAN"}, {"name": "persons", "value": "MURRAY, ROSEMARIE"}, {"name": "persons", "value": "ROLDON, JUAN"}, {"name": "glocations", "value": "NEW YORK STATE"}, {"name": "subject", "value": "STATES (US)"}, {"name": "subject", "value": "PRISONS AND PRISONERS"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "COLLEGES AND UNIVERSITIES"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "SPECIAL SECTIONS"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Abby", "lastname": "Ellin"}], "original": "By Abby Ellin"}, "document_type": "article", "pub_date": "2003-08-03T00:00:00Z", "section_name": "Education; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The European Commission accused AstraZeneca of misusing European drug patent and marketing rules to protect its blockbuster ulcer treatment from generic equivalents, Europe's competition regulator said today. Mario Monti, the competition commissioner, said in a statement today that the antitrust case centered on ''suspected misuses of governmental systems and procedures which have the effect of blocking or delaying entry to the market of cheaper medicines.''", "headline": {"main": "AstraZeneca Is Accused Of Misusing Patent Rules"}, "abstract": "European Commission accuses AstraZeneca of misusing European drug patent and marketing rules to protect its blockbuster ulcer treatment, Losec, from generic equivalents (S)", "print_page": "1", "word_count": 622, "_id": "4fd243c48eb7c8105d7dd703", "snippet": "The European Commission accused AstraZeneca of misusing European drug patent and marketing rules to protect its blockbuster ulcer treatment from generic equivalents, Europe's competition regulator said today.    Mario Monti, the competition...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/08/01/business/astrazeneca-is-accused-of-misusing-patent-rules.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "ASTRAZENECA"}, {"name": "organizations", "value": "EUROPEAN COMMISSION"}, {"name": "subject", "value": "ULCERS"}, {"name": "subject", "value": "GENERIC"}, {"name": "subject", "value": "LOSEC (DRUG)"}, {"name": "subject", "value": "INVENTIONS AND PATENTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Paul", "lastname": "MELLER"}], "original": "By PAUL MELLER"}, "document_type": "article", "pub_date": "2003-08-01T00:00:00Z", "section_name": "Technology; Health; Business"}], "meta": {"hits": 4, "offset": 0, "time": 87}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}